Two more Peninsula IPOs tell the story of biotech's investment boom

One is a pioneer in liquid biopsies that already has tests on the market to uncover cancer; the other is a small company that only recently started its first clinical trial.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.